Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Sanofi hired Muzammil “Muz” Mansuri as executive vice president, strategy and business development. Previously, he worked at Gilead Sciences, where he was senior vice president, R&D strategy and corporate development. He was also chief executive officer at CGI Pharmaceuticals and, before that, worked at Bristol-Myers Squibb.

Achillion Pharmaceuticals hired Martha Manning as executive vice president, general counsel;

Achillion Pharmaceuticals hired Amy Jennings as senior vice president of regulatory affairs;

Merial hired Susan Sholtis as president of its North American operations;

C4 Therapeutics hired Andrew Phillips as chief scientific officer;

Johnson & Johnson says chief communications officer Maggie FitzPatrick is leaving;

Gilead Sciences promoted Katie Watson, to executive vice president, human resources;

Merck KGaA named Marc Horn as managing director of its China unit;

Patheon hired Steve Lam as senior vice president of its biologics business;

Medgenics promoted Brian Piper to chief financial officer;

Celyad hired Richard Mountfield as vice president of global regulatory affairs;

Voyager Therapeutics promoted Jeff Goater to chief financial officer;

Eagle Pharmaceuticals hired Michael Moran as US head of sales;

Lion Biotechnologies hired Dr. Steven Fischkoff as chief medical officer;

Deltanoid Pharmaceuticals hired Douglas Jermasek as chief executive officer;

Five Prime Therapeutics hired Kevin Baker as senior VP, development sciences;

Five Prime Therapeutics promoted Dr. Robert Sikorski to senior VP, global clinical development;

Emmaus Life Sciences named Lan Tran as co-president;

Emmaus Life Sciences named Peter Ludlum as co-president;

Oasmia Pharmaceutical hired Dr. Ulf Jungnelius as senior medical advisor;

Illuminate hired Aimee Pelletier as senior project director;

Illuminate hired Kristen Cartwright as project manager;

Illuminate hired Nicola Hassapis as project manager.